Chapter 441 (1/2)

Cario's office was filled with smoke. He smoked cigars one after another, which was very stressful.

The above is urging the progress of the laboratory, but the current progress of the laboratory is no progress.

”Boss, have you ever heard of Europe?”

Subordinate Sean took the initiative to light a cigar for kario and said, ”the tassel 3 mobile phone equipped with biochip has been sold to Europe, and the market feedback is very good. It is said that Warwick has invested 200000 mobile phones in Europe, but all of them have been sold out. Many consumers are still looking for Xia Guo to take the products there, and continue like this, There will no longer be a market for American scientific and technological products in the European market. ”

”Of course I know, man! So now our laboratory is under great pressure. Which guys above have been urging very hard. Now I regret receiving this task. Shouldn't this kind of thing be handed over to those semiconductor and chip laboratories? ”

That's what I said, but Cario was really worried.

It has been three months since the experimental task, and the laboratory has got nothing.

Above, Cario's experimental team has been said to be useless by some people.

Some even demanded that Cario be held accountable.

After hearing the news, Cario felt that he had broken into a ghost. If the task was not completed, he was annoyed.

”Take it easy, boss. The meaning of those politicians is for their political achievements. They should come to the laboratory to do experiments themselves.” Sean understood caryou's current situation very well. ”They thought they would pay us to do experiments, and we would be able to get the same results. If there is such an effect, what do you want us to do? In fact, the relevant biological companies produce the same biochip as the origin group! ”

We make complaints about Tucao, but we must make complaints about experiments.

Moreover, Cario's war intention has been provoked by the origin group. He is determined to find out the shortcomings of biochip.

Just then, Cario received a call.

It's congressman nitley.

Nitley, one of his identities is a congressman, the other is the boss of Gilead science, the largest biomedical company in the United States, and the largest financier of Cario team.

The company's main business scope is biomedicine and treatment of viral diseases, tumors and fibrosis. The company's business is also all over the world. In particular, biomedicine has made a lot of money all over the world, with a market value of more than 100 billion meters.

On the surface, Gilead science has no conflict with the business of the origin group, but in fact, Gilead science suffered a big loss from the origin group a few years ago.

Gilead science has a business that is the research and treatment of fibrosis, which involves pulmonary fibrosis.

In the past, drug development and some medical methods produced by Gilead science were the only way to treat pulmonary fibrosis.

Their drugs and treatments have been promoted all over the world, and they are standardized therapies in many countries and hospitals.

In other words, Gilead science monopolized the treatment methods and drugs of lung fiber.

But all this changed after the origin group developed chloromycetes.

Although the treatment methods and methods of Gilead science company can control the condition of pulmonary fiber, they can not completely treat pulmonary fibrosis. Patients can control the condition for a period of time, but they will still face death after a long time.

The chloromycetes studied by the origin group can completely liberate the lungs of patients, which is equivalent to completely solving the problem of pulmonary fibrosis.

In contrast, it is obvious whose technology is safer and more in line with the needs of patients.

After the origin group developed chloromycetes, Gilead science basically went to the Xiaguo market.

What makes Gilead science company hate more is still behind. The origin group actually cooperated with Mexico to establish a medical center in Mexico, and the biggest project of the medical center is to treat pulmonary fibrosis.

Mexico is not far from the United States, and its location is just able to cover the whole of America.

Patients from North America and Latin America, including the United States, often go to treatment centers in Mexico.

This approach of the origin group completely broke the financial path of Gilead science company on fibrosis treatment.

In this way, how can Gilead science not hate the origin group.

Now the origin group has developed biochips, which can be said to span the development of biomedicine and electronic technology.

Moreover, the value that biochip will create is obvious. The value created by the biochip industry of biology must far exceed the value created by biology in medicine.

The global market value of semiconductors has reached tens of trillions of meters. How can Gilead science not be interested in such an attractive industry?

In this context, Gilead science company is very interested in developing biochips. It has also invested hundreds of millions of dollars in Cario's laboratory, hoping that Cario's laboratory can develop corresponding technologies.

Although Cario is one of the heads of the national life science laboratory of the United States, he is also the most famous expert in molecular biology and virology.

But like other scientists in the laboratory, they will also have their own financiers to carry out some research according to the requirements of the financiers.

Nitley said: ”Mr. carrio, I have invested nearly $200 million in your laboratory. Now it is more than three months from the beginning. It is reasonable to say that this time is not short. I'm not asking you to develop a biochip immediately, but I hope to hear some exciting experimental progress. Yes, I need your experimental progress. But, my man, you haven't reported any good news to me so far. ”

”Now there are many biological laboratories in New York that are interested in my investment. If you can't get any useful results, I may want to put the project in other laboratories,” nitley said

Cario was really worried when he heard this.

If his experimental team can't get funds, it will be very difficult in the future.

Moreover, Cario himself is a person who cares about reputation very much. If within the industry, we all know that Cario was cancelled because of poor experiment, and his personal reputation was destroyed in the academic community.